91滴滴

Biobank of the 91滴滴 is creating genetic map of Poles under EGA!

The Biobank of the 91滴滴, already as part of the European Genome-phenome Archive (EGA), is going to create a modern database on genetic variability of Poles. Thanks to this, scientific institutions from Poland and Europe will be able to use genomic sequences of Poles, available free of charge, in the implementation of their own research projects. The goal is, as usually, to develop better medications and treatments for us, patients. The important fact is that all the materials will be made available in line with the existing GDPR - General Data Protection Regulation and based on the approval of a bioethic committee. For realization of the project the Biobank has received PLN 10 million, the vast majority of the EU funds.

 

Opublikowano: 10 March 2021
Photo of the President of the City of Lodz, the UL Rector and the project manager

A genome is a complete set of genetic information of a living organism, an exome, in turn, is a collection of exons or genome fragments that contain information about the sequence encoding genes from which functional peptides and proteins are formed. Thanks to the new project of the UL Biobank, genomes and exomes of Poles from all regions of the country will be stored in one place. This is a continuation of operation of one of the fastest developing units of the 91滴滴. Now, the Biobank of the 91滴滴 will be the first Polish instance of the European Genome-phenome Archive (EGA).

- This is a response to the GDPR coming into force. Genetic data generated by Polish scientists and concerning Polish population will be stored on the territory of the Republic of Poland in accordance with the relevant legal regulations and will be available to the world of science only with the consent of the authors of the collection. We believe that thanks to this initiative more Polish scientific units will be able to participate in international research cooperations, and that the sensitive data on Polish population will be appropriately secured - explains mgr. in偶. B艂a偶ej Marciniak from the UL Biobank, the project manager.

Development of personalised medicine means that there are more and more advanced and precise treatment schemes, which frequently depend on a specific genotype of a patient. The lack of available genetic data of a given population may translate into its exclusion from contemporary therapies. Researchers from the 91滴滴 want this data to be easily accessible to professional scientific institutions and thus, they want it to enable prevention of as many civilisation diseases as possible.

Building a modern, highly efficient gene digitization centre at the 91滴滴 will constitute the last but also a significant effect of the project.

- Taking advantage of the favourable conditions (logistics centre, important communication routes), Lodz may become an important biotechnology hub providing highly specialised services at an international level and supporting pharmaceutical and biotechnology companies operating throughout the region - says B艂a偶ej Marciniak.

The Biobank of the 91滴滴 started its operation as a population biobank. Such units deal with problems of the whole populations at a very general level, but knowledge generated by them has a chance to be used in individual therapies - of rare diseases, civilisation diseases or personalised medicine. The project entitled "Genomowa mapa polski w otwartym dost臋pie - digitalizacja zasob贸w Biomolekularnych Pracowni Biobank U艁" [Genomic map of Poland in open access - digitization of Biomolecular resources of the Biobank Laboratory of the 91滴滴] is financed under the Operational Programme Digital Poland.


Source: Biobank UL,

Edit: Promotion Centre, UL

91滴滴

 

Narutowicza 68, 90-136 LODZ

fax: 00 48 42/665 57 71, 00 48 42/635 40 43

NIP: 724 000 32 43

© 91滴滴 2026